NCT00080886View on ClinicalTrials.gov

Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2002

Primary Completion Date

November 1, 2005

Study Completion Date

March 12, 2015

Conditions

Lymphoma

Interventions

BIOLOGICAL

rituximab

DRUG

carmustine

DRUG

cytarabine

DRUG

etoposide

DRUG

melphalan

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

68198-7680

University of Nebraska Medical Center, Eppley Cancer Center, Omaha

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Nebraska

OTHER

NCT00080886 - Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter